Publikasi Scopus 2024 per tanggal 31 Mei 2024 (409 artikel)

Hayashi R.; Okumura H.; Isono M.; Yamauchi M.; Unami D.; Lusi R.T.; Yamamoto M.; Kato Y.; Uchihara Y.; Shibata A.
Hayashi, Ryota (59141537100); Okumura, Hikaru (59142122600); Isono, Mayu (56367792400); Yamauchi, Motohiro (8307897300); Unami, Daiki (59141732600); Lusi, Rahmartani Tania (59141337500); Yamamoto, Masamichi (56134058600); Kato, Yu (58930092200); Uchihara, Yuki (57022057000); Shibata, Atsushi (8323572900)
59141537100; 59142122600; 56367792400; 8307897300; 59141732600; 59141337500; 56134058600; 58930092200; 57022057000; 8323572900
Inhibition of intracellular ATP synthesis impairs the recruitment of homologous recombination factors after ionizing radiation
2024
Journal of Radiation Research
65
3
263
271
8
0
Division of Molecular Oncological Pharmacy, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan; Hospital Campus Laboratory, Radioisotope Center, Central Institute of Radioisotope Science and Safety Management, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan; Department of Radiation Oncology, Faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo National General Hospital, Jl. Diponegoro No.71, Jakarta Pusat, DKI Jakarta, 10430, Indonesia; Department of Research Promotion and Management, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan
Hayashi R., Division of Molecular Oncological Pharmacy, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan; Okumura H., Division of Molecular Oncological Pharmacy, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan; Isono M., Division of Molecular Oncological Pharmacy, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan; Yamauchi M., Hospital Campus Laboratory, Radioisotope Center, Central Institute of Radioisotope Science and Safety Management, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan; Unami D., Division of Molecular Oncological Pharmacy, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan; Lusi R.T., Department of Radiation Oncology, Faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo National General Hospital, Jl. Diponegoro No.71, Jakarta Pusat, DKI Jakarta, 10430, Indonesia; Yamamoto M., Department of Research Promotion and Management, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan; Kato Y., Division of Molecular Oncological Pharmacy, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan; Uchihara Y., Division of Molecular Oncological Pharmacy, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan; Shibata A., Division of Molecular Oncological Pharmacy, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan
Ionizing radiation (IR)-induced double-strand breaks (DSBs) are primarily repaired by non-homologous end joining or homologous recombination (HR) in human cells. DSB repair requires adenosine-5′-triphosphate (ATP) for protein kinase activities in the multiple steps of DSB repair, such as DNA ligation, chromatin remodeling, and DNA damage signaling via protein kinase and ATPase activities. To investigate whether low ATP culture conditions affect the recruitment of repair proteins at DSB sites, IR-induced foci were examined in the presence of ATP synthesis inhibitors. We found that p53 binding protein 1 foci formation was modestly reduced under low ATP conditions after IR, although phosphorylated histone H2AX and mediator of DNA damage checkpoint 1 foci formation were not impaired. Next, we examined the foci formation of breast cancer susceptibility gene I (BRCA1), replication protein A (RPA) and radiation 51 (RAD51), which are HR factors, in G2 phase cells following IR. Interestingly, BRCA1 and RPA foci in the G2 phase were significantly reduced under low ATP conditions compared to that under normal culture conditions. Notably, RAD51 foci were drastically impaired under low ATP conditions. These results suggest that HR does not effectively progress under low ATP conditions; in particular, ATP shortages impair downstream steps in HR, such as RAD51 loading. Taken together, these results suggest that the maintenance of cellular ATP levels is critical for DNA damage response and HR progression after IR. © 2024 The Author(s). Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.
ATP shortage; DSB repair; foci formation; homologous recombination; ionizing radiation
Adenosine Triphosphate; BRCA1 Protein; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Repair; Histones; Homologous Recombination; Humans; Intracellular Space; Rad51 Recombinase; Radiation, Ionizing; Replication Protein A; Biosynthesis; DNA; Enzymes; Radiation shielding; adenosine triphosphate; BRCA1 protein; histone; Rad51 protein; replication factor A; Adenosine-5-triphosphate; Adenosine-5′-triphosphate shortage; Condition; Double strand break repair; Double strand breaks; Focus formation; Homologous recombination; Protein kinase activities; Radiation-induced; Recombination factors; biosynthesis; DNA repair; double stranded DNA break; homologous recombination; human; intracellular space; ionizing radiation; metabolism; radiation response; tumor cell line; Ionizing radiation
Naito Foundation; Astellas Foundation for Research on Metabolic Disorders; Sumitomo Foundation, SF; Takeda Science Foundation, TSF; Suntory Foundation for Life Sciences Bioorganic Research Institute; Kobayashi Foundation for Cancer Research, Foundation for Promotion of Cancer Research; Princess Takamatsu Cancer Research Fund; Japan Agency for Medical Research and Development, AMED, (JP23zf0127008, JP22zf0127008); Japan Agency for Medical Research and Development, AMED; National Cancer Center, NC
This work was supported by JSPS KAKENHI (JP21H03596; AMED under Grant Numbers JP22zf0127008 and JP23zf0127008), Takeda Science Foundation, Sumitomo Foundation, Suntory Foundation for Life Sciences Bioorganic Research Institute, Kobayashi Foundation for Cancer Research, Foundation for Promotion of Cancer Research, Naito Foundation, Princess Takamatsu Cancer Research Fund, Astellas Foundation for Re
Oxford University Press
04493060
38461549
Article
Q2
572
9052